Endogenous somatostatin receptors mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells

Brain Research

Volumn 975, Issue 1-2, 2003, Pages 120-128

  Rhie, Duck Joo ^a   Sung, Jong Ho ^a   Ha, U Sin ^a   Kim, Hee Jung ^a   Min, Do Sik ^a   Hahn, Sang June ^a   Kim, Myung Suk ^a   Jo, Yang Hyeok ^a   Yoon, Shin Hee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Calcium; G protein; Inositol phosphate; Phospholipase C; Somatostatin receptor

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCIUM ION; INOSITOL PHOSPHATE; PERTUSSIS TOXIN; PHOSPHATE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; RECEPTOR BLOCKING AGENT; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN RECEPTOR; THAPSIGARGIN; TRITIUM; UNCLASSIFIED DRUG; XESTOSPONGIN C;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM DEPLETION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; GLIOMA CELL; IMAGING; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0038404819     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02596-4     Document Type: Article

References (54)

1. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS Lett. 348:1994;192-196.
2. Brown D.A., Higashida H. Membrane current responses of NG108-15 mouse neuroblastoma×rat glioma hybrid cells to bradykinin. J. Physiol. (London). 397:1998;167-184.
3. Burns C., Raulf F., Hoyer D., Schloos J., Lubbert H., Weckbecker G. Binding properties of somatostatin receptors subtypes. Metabolism. 45:1996;17-20.
4. Camps M., Carozzi A., Schnabel P., Scheer A., Parker P.J., Gierschik P. Isozyme-selective stimulation of phospholipase C-β2 by G protein βγ subunits. Nature. 360:1992;684-686.
5. Carozzi A., Camps M., Gierschik P., Parker P.J. Activation of phosphatidylinositol lipid-specific phospholipase C-β3 by G-protein βγ-subunits. FEBS Lett. 315:1993;340-342.
6. Chen L., Huang L.-Y. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron. 7:1991;319-326.
7. 2+ concentration and insulin release in the presence of arginine vasopressin in clonal HIT-T15 beta-cells. Biochem. J. 364:2002;33-39.
8. Connor M., Yeo A., Henderson G. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 120:1997;455-463.
9. 2+ concentration by somatostatin and alpha 1-adrenergic agonists in mouse astrocytes. J. Physiol. (Paris). 86:1992;31-38.
10. Dodd J., Kelly J.S. Is somatostatin an excitatory transmitter in the hippocampus? Nature. 273:1978;674-675.
11. Gafni J., Munsch J.A., Lam T.H., Catlin M.C., Costa L.G., Molinski T.F., Pessah I.N. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron. 19:1997;723-733.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
13. Helper J.R., Gilman A.G. G proteins. Trends Biochem. Sci. 17:1992;383-387.
14. Hynds D.L., Burry R.W., Yates A.J. Gangliosides inhibit growth factor-stimulated neurite outgrowth in SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 47:1997;617-625.
15. Jhon D.Y., Lee H.H., Park D., Lee C.W., Lee K.H., Yoo O.J., Rhee S.G. Cloning, sequencing, purification, and Gq-dependent activation of phospholipase C-β3. J. Biol. Chem. 268:1993;6654-6661.
16. Jin W., Lee N.M., Loh H.H., Thayer S.A. Dual excitatory and inhibitory effects of opioids intracellular calcium in neuroblastoma×glioma hybrid NG108-15 cells. Mol. Pharmacol. 42:1992;1083-1089.
17. Jin W., Lee N.M., Loh H.H., Thayer S.A. Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells. J. Neurosci. 14:1994;1920-1929.
18. Katz A., Wu D., Simon M.I. Subunits βγ of heterotrimeric G protein activate β2 isoform of phospholipase C. Nature. 360:1992;686-689.
19. Keshmirian J., Bray G., Carbonetto S. The extracellular matrix modulates the response of PC12 cells to nerve growth factor: cell aggregation versus neurite outgrowth on 3-dimensional laminin substrata. J. Neurocytol. 18:1989;491-504.
20. Krulich L., Dhariwal A.P.S., McCann S.M. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology. 83:1968;783-790.
21. Kubota A., Yamada Y., Kagimoto S., Yasuda K., Someya Y., Ihara Y., Okamoto Y., Kozasa T., Seino S., Seino Y. Multiple effector coupling of somatostatin receptor subtype SSTR1. Biochem. Biophys. Res. Commun. 204:1994;176-186.
22. Lee C.W., Lee K.H., Lee S.B., Park D., Rhee S.G. Regulation of phospholipase C-β4 by ribonucleotides and the α subunit of Gq. J. Biol. Chem. 269:1994;25335-25338.
23. 2+ store in neuroblastoma×glioma hybrid NG108-15 cells. Am. J. Physiol. 264:1992;C641-C653.
24. Matsuoka N., Kaneko S., Satoh M. Somatostatin auguments long term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampal slices. Brain Res. 553:1991;188-194.
25. McKenzie F.R., Milligan G. Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2. Biochem. J. 267:1990;391-398.
26. 2+/calmodulin-dependent protein kinase II, and tyrosine phosphorylation are involved in carbachol-induced phospholipase D activation in Chinese hamster ovary cells expressing muscarinic acetylcholine receptor of Caenorhabditis elegans. J. Neurochem. 75:2000;274-281.
27. Murthy K.S., Coy D.H., Makhlouf G.H. Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-β3 by Gβγ and inhibition of adenylyl cyclase by Gαi1 and Gαo. J. Biol. Chem. 271:1996;23458-23463.
28. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
29. 2+ mobilization between bradykinin and agonists for pertussis toxin-sensitive G-protein-coupled receptors in NG 108-15 cells. FEBS Lett. 301:1992;223-226.
30. Olpe H.R., Balcar V.J., Bittiger H., Rink H., Sieber P. Central actions of somatostatin. Eur. J. Pharmacol. 63:1980;127-133.
31. Park D., Jhon D.Y., Lee C.W., Lee K.H., Rhee S.G. Activation of phospholipase C isozymes by G protein βγ subunits. J. Biol. Chem. 268:1993;4573-4576.
32. 2+ block without depolarization. Br. J. Pharmacol. 130:2000;557-566.
33. Rauvala H. Neurite outgrowth of neuroblastoma cells: dependence on adhesion surface-cell surface interactions. J. Cell Biol. 98:1984;1010-1016.
34. Reisine T., Bell G.I. Molecular biology of somatostatin receptors. Endocr. Rev. 16:1995;427-442.
35. Renaud L.P., Martin J.B., Brazeau P. Depressant action of TRH, LH-RH and somatostatin on activity of central neurons. Nature. 255:1975;233-235.
36. Rhee S.G., Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272:1997;15045-15048.
37. Romoser V.A., Graves T.K., Wu D., Jiang H., Hinkle P.M. Calcium responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and somatostatin in phospholipase Cβ3 knockout mice. Mol. Endocrinol. 15:2001;125-135.
38. 3- and ryanodine-sensitive calcium stores in presynaptic varicosities of NG108-15 (rodent neuroblastoma×glioma hybrid) cells. J. Physiol. 529:2000;307-319.
39. Sarne Y., Gafni M. Determinants of the stimulatory opioid effect on intracellular calcium in SK-N-SH and NG108-15 neuroblastoma. Brain Res. 722:1996;203-206.
40. Sarret P., Nouel D., Dal Farra C., Vincent J.-P., Beaudet A., Mazella J. Receptor-mediated internalization is critical for the inhibition of the expression of growth hormone by somatostatin in the pituitary cell line AtT-20. J. Biol. Chem. 274:1999;19294-19300.
41. Siehler S., Hoyer D. Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity. Naunyn Schmiedeberg's Arch. Pharmacol. 360:1999;522-532.
42. Smrcka A.V., Sternweis P.C. Regulation of purified subtypes of phosphatidylinositol-specific phospholipase Cβ by G protein α and βγ subunits. J. Biol. Chem. 268:1993;9667-9674.
43. Strassheim D., Law P.Y., Loh H.H. Contribution of phospholipase C-β3 phosphorylation to the rapid attenuation of opioid-activated phosphoinositide response. Mol. Pharmacol. 53:1998;1047-1053.
44. Taussig R., Sanchez S., Rifo M., Gilman A.G., Belardetti F. Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins. Neuron. 8:1992;799-809.
45. 2+ mobilization in rat AR42J pancreas cells. Biochem. Biophys. Res. Commun. 214:1995;81-85.
46. 2+ mobilization. Biochem. Biophys. Res. Commun. 200:1994;986-992.
47. Twery M.J., Gallagher J.P. Somatostatin hyperpolarizes neurons and inhibits spontaneous activity in the rat dorsolateral septal nucleus. Brain Res. 497:1989;315-324.
48. Vanetti M., Vogt G., Hollt V. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett. 331:1993;260-266.
49. Vanetti M., Ziolkowska B., Wang X., Horn G., Hollt V. mRNA distribution of two isoforms of somatostatin receptor 2 (mSSTR2A and mSSTR2B) in the mouse brain. Mol. Brain Res. 27:1994;45-50.
50. Wang H.L., Reisine T., Dichter M. Somatostatin-14 and somatostatin-28 inhibit calcium currents in rat neocortical neurons. Neuroscience. 38:1990;335-342.
51. Wilkinson G.F., Feniuk W., Humphrey P.P. Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism. Br. J. Pharmacol. 121:1997;91-96.
52. 2+ produced by somatostatin and acetylcholine in ciliary body epithelial cells. Exp. Eye Res. 64:1997;627-635.
53. Yasuda K., Rens-Domiano S., Breder C.D., Law S.F., Saper C.B., Reisine T., Bell G.I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. J. Biol. Chem. 267:1992;20422-20428.
54. 2+ stores in NG108-15 cells. Mol. Pharmacol. 56:1999;902-908.